Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Boehringer Ingelheim
Harvard Business School
Mallinckrodt
McKinsey

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

SODIUM THIOSULFATE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

When do Sodium Thiosulfate patents expire, and when can generic versions of Sodium Thiosulfate launch?

Sodium Thiosulfate is a drug marketed by Us Army and Hope Pharms and is included in two NDAs. There are three patents protecting this drug.

This drug has twenty-one patent family members in eleven countries.

The generic ingredient in SODIUM THIOSULFATE is sodium thiosulfate. There are one thousand four hundred and seventy-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sodium thiosulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Sodium Thiosulfate

A generic version of SODIUM THIOSULFATE was launched as sodium thiosulfate by HOPE PHARMS on December 14th, 2019.

Summary for SODIUM THIOSULFATE
Drug patent expirations by year for SODIUM THIOSULFATE
Recent Clinical Trials for SODIUM THIOSULFATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, LimogesPhase 2
University of Central FloridaPhase 4
National Institute of Environmental Health Sciences (NIEHS)Phase 2

See all SODIUM THIOSULFATE clinical trials

Synonyms for SODIUM THIOSULFATE
10102-17-7 (pentahydrate)
1374442-73-5
13773-27-8
220945-47-1
7772-98-7
AC1L2NGO
AC1Q1USN
ACMC-1BLMJ
AI3-01237
AKHNMLFCWUSKQB-UHFFFAOYSA-L
AKOS015856704
AKOS016372312
anhydrous sodium thiosulfate
BP-21059
CHEBI:132112
CHEMBL3753202
Chlorine Control
Chlorine Cure
CTK2H7219
Declor-It
disodium sulfurothioate
Disodium thiosulfate
DTXSID9042417
EC 231-867-5
EINECS 231-867-5
FT-0696570
HSDB 592
Hypo
Hypo (VAN)
Hypo alcohol
Hypo alcohol, in ethanol
Hyposulphite of soda
I14-16584
KS-00000VC8
KSC377E1T
L0IYT1O31N
LS-153406
MFCD00003499
MolPort-003-926-155
MolPort-006-118-733
Na2O3S2
Na2S2O3
NSC 45624
RP22166
RTR-031296
SC-74795
Sodium oxide sulfide
Sodium oxide sulfide (Na2S2O3)
sodium sulfothioate
sodium thio-sulfate
sodium thiosulfat
sodium thiosulfate (anhydrous)
Sodium thiosulfate (Na2S2O3)
Sodium thiosulfate 2.5M solution (+/- 0.1M) pH 7.0 - 9.0 (Sodium carbonate added as a preservative)
Sodium thiosulfate anhydrous
Sodium thiosulfate concentrate
Sodium thiosulfate solution, 0.01 M
Sodium thiosulfate solution, 0.025 M
Sodium thiosulfate solution, 0.1 M
Sodium thiosulfate solution, 1 M
Sodium thiosulfate solution, 2 g/dL in deionized water
Sodium thiosulfate solution, Silver stain kit component, 0.5 % (w/v) sodium thiosulfate in H2O
Sodium thiosulfate, >=99.99% trace metals basis
Sodium thiosulfate, 0.1 N standard solution
Sodium Thiosulfate, 0.1N Volumetric Solution
Sodium thiosulfate, 98.5%, extra pure, anhydrous
Sodium thiosulfate, 99%, for analysis, anhydrous
Sodium thiosulfate, anhydrous
Sodium thiosulfate, anhydrous, >=98% (calc. to the dried substance)
Sodium thiosulfate, anhydrous, Trace metals grade 99.99%
Sodium thiosulfate, AR, >=98%
Sodium thiosulfate, LR, >=97%
Sodium thiosulfate, p.a., 98.0%
Sodium thiosulfate, purum p.a., anhydrous, >=98.0% (RT)
Sodium thiosulfate, ReagentPlus(R), 99%
Sodium thiosulfate, SAJ first grade, >=90.0%
Sodium thiosulfate, Vetec(TM) reagent grade, 99%
Sodium thiosulfate,anhydrous
Sodium thiosulphate
Sodium thiosulphate (Na2S2O3)
sodiumthiosulfate
Thiosulfuric acid (H2S2O3) disodium salt
Thiosulfuric acid (H2S2O3), disodium salt
Thiosulfuric acid (H2S2O3), sodium salt (1:2)
Thiosulfuric acid, disodium salt
TR-031296
TRA0058020
UNII-L0IYT1O31N
X5843

US Patents and Regulatory Information for SODIUM THIOSULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Army SODIUM THIOSULFATE sodium thiosulfate INJECTABLE;INJECTION 020166-001 Feb 14, 1992 DISCN No No   Start Trial   Start Trial   Start Trial
Hope Pharms SODIUM THIOSULFATE sodium thiosulfate SOLUTION;INTRAVENOUS 203923-001 Feb 14, 2012 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Hope Pharms SODIUM THIOSULFATE sodium thiosulfate SOLUTION;INTRAVENOUS 203923-001 Feb 14, 2012 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for SODIUM THIOSULFATE

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0806968 SPC/GB07/011 United Kingdom   Start Trial PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003
1499331 13C0055 France   Start Trial PRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
0480717 SPC/GB98/025 United Kingdom   Start Trial PRODUCT NAME: MONTELUKAST, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY MONTELUKAST SODIUM; REGISTERED: FI 12766 19970825; FI 12767 19970825; UK 00025/0357 19980115; UK 00025/0358 19980115
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
AstraZeneca
Baxter
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.